financetom
Business
financetom
/
Business
/
ACC Q1 net profit beats estimate, jumps 38% to Rs 346 crore
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ACC Q1 net profit beats estimate, jumps 38% to Rs 346 crore
Apr 23, 2019 8:55 AM

Cement maker ACC Ltd on Tuesday reported a 38 percent year-on-year (YoY) jump in net profit at Rs 346 crore for the first quarter ended March 2019.

The company, which follows January-December as a fiscal year, had posted a net profit of Rs 245 crore in the corresponding quarter last year.

CNBC-TV18 Polls had predicted a profit of Rs 315 crore for the quarter under review.

Total consolidated income from operations rose to Rs 3,919 crore in the January-March quarter from Rs 3,625 crore in the same period a year ago.

Net sales during the quarter went up by 8 percent to Rs 3,850 crore compared to Rs 3,557 crore for the same quarter last year. Operating EBITDA for the quarter registered a growth of 8 percent to Rs 532 crore as against Rs 492 crore during the same quarter of the previous year.

"Our three-pronged strategy of customised solutions for consumers, focus on and powering ACC's strong growth trajectory. Our ready mix concrete business has demonstrated consistently strong volume growth quarter after quarter. We are also investing in a pipeline of solutions and products including a portfolio of dry mix products," said Neeraj Akhoury, managing director and chief executive officer.

Ready mix concrete business continued to deliver robust growth as volumes of ready-mix concrete grew strongly at 19 percent and volumes of value-added solutions (VAS) also grew significantly in Q1FY19 YoY, the cement major said.

The company said eight new plants were commissioned in the quarter bringing the total number of ready-mix concrete plants to 80.

First Published:Apr 23, 2019 5:55 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Soccer-Juventus held goalless in home clash with Roma
Soccer-Juventus held goalless in home clash with Roma
Sep 1, 2024
TURIN, Italy, Sept 1 (Reuters) - Juventus were held to a goalless draw by visiting AS Roma in Serie A on Sunday as Thiago Motta's side dropped their first points of the campaign. The most promising chance arrived just before the break when Juventus forward Dusan Vlahovic struck with first touch from around the penalty spot but Roma keeper Mile...
POET Technologies Reorganizes Engineering Team With Scheduled Closing of US Operation
POET Technologies Reorganizes Engineering Team With Scheduled Closing of US Operation
Sep 1, 2024
08:27 AM EDT, 08/29/2024 (MT Newswires) -- POET Technologies ( POET ) said Thursday that it has established a global engineering organization in Singapore to reorganize its engineering team for the optimization of design, component engineering, and new product introduction operations globally. As part of the reorganization the firm will transfer its engineering design and manufacturing interface functions to Shenzhen,...
Royal Caribbean Cruises Insider Sold Shares Worth $518,446, According to a Recent SEC Filing
Royal Caribbean Cruises Insider Sold Shares Worth $518,446, According to a Recent SEC Filing
Sep 1, 2024
04:45 PM EDT, 08/30/2024 (MT Newswires) -- Laura H Bethge, President, Celebrity Cruises, on August 29, 2024, sold 3,073 shares in Royal Caribbean Cruises ( RCL ) for $518,446. Following the Form 4 filing with the SEC, Bethge has control over a total of 27,475 shares of the company, with 27,388 shares held directly and 87 controlled indirectly. SEC Filing:...
Aptose Biosciences Up 65% In US After Hours As Gets US$10 Million Loan From Hanmi Pharmaceutical
Aptose Biosciences Up 65% In US After Hours As Gets US$10 Million Loan From Hanmi Pharmaceutical
Sep 1, 2024
04:47 PM EDT, 08/30/2024 (MT Newswires) -- Aptose Biosciences ( APTO ) was at last look up near 65% on Friday afternoon after saying it has received a US$10 million loan from Hanmi Pharmaceutical. A statement noted the loan is convertible either as prepayment for future milestone obligations or repayable after the expected completion of a triple-drug combination trial with...
Copyright 2023-2026 - www.financetom.com All Rights Reserved